Webinar On Differences between ICH-GCP and FDA regulations

(www.complianceonline.com)

The biopharmaceutical industry is also targeted by globalization. Biopharmaceuticals companies are running clinical trials all over the world and in order to lower the costs data is transferred between countries. In order to reduce time, to lower costs and to avoid delays in submission and market approval clinical professionals need to know the similarities and differences between the FDA and ICH-GCP requirements. . This presentation will help with preparing better for submitting data obtained from outside US countries to the FDA and from US to outside FDA regulated countries.